We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
RHOFADE Mayne Pharma International Pty Ltd
Product name
RHOFADE
Accepted date
Jul-2025
Active ingredients
oxymetazoline hydrochloride
Proposed indication
Rhofade (oxymetazoline hydrochloride) is a topical treatment for ongoing facial redness caused by rosacea in adults. Rosacea is a chronic inflammatory skin condition that primarily affects the face.
Application type
C (new indication)
Publication date
Jul-2025